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a b s t r a c t
In this paper we report differential decoding of the ultradian corticosterone signal by glucocorticoid
target tissues. Pulsatile corticosterone replacement in adrenalectomised rats resulted in different dy-
namics of Sgk1 mRNA production, with a distinct pulsatile mRNA induction proﬁle observed in the pi-
tuitary in contrast to a non-pulsatile induction in the prefrontal cortex (PFC). We further report the ﬁrst
evidence for pulsatile transcriptional repression of a glucocorticoid-target gene in vivo, with pulsatile
regulation of Pomc transcription in pituitary. We have explored a potential mechanism for differences in
the induction dynamics of the same transcript (Sgk1) between the PFC and pituitary. Glucocorticoid
receptor (GR) activation proﬁles were strikingly different in pituitary and prefrontal cortex, with a
signiﬁcantly greater dynamic range and shorter duration of GR activity detected in the pituitary,
consistent with the more pronounced gene pulsing effect observed. In the prefrontal cortex, expression
of Gilz mRNA was also non-pulsatile and exhibited a signiﬁcantly delayed timecourse of increase and
decrease when compared to Sgk1, additionally highlighting gene-speciﬁc regulatory dynamics during
ultradian glucocorticoid treatment.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The secretion of glucocorticoid hormones from the adrenal
glands of mammals is regulated by the hypothalamic-pituitary-
adrenal (HPA) axis and ﬂuctuates greatly over the course of a day.
Levels of endogenous glucocorticoids (corticosterone in rats and
cortisol in humans) circulating in the bloodstream not only rise in
response to stress, but exhibit a well established circadian pattern
in healthy unstressed individuals with glucocorticoid levels rising
prior to waking and decreasing prior to sleep (Lightman and
Conway-Campbell, 2010; Biddie et al., 2012). Underlying these
circadian ﬂuctuations exists a highly conserved ultradian gluco-
corticoid secretion pattern with pulses of endogenous glucocorti-
coid secreted at regular intervals (approximately 60 min in rats
(Windle et al., 1998a, 1998b) and 60e90 min in humans (Veldhuis
et al., 1989)) that arise due to an intrinsic positive feed-forward
and negative feedback loop in the HPA axis (Walker et al., 2010,
2012).
Despite the highly dynamic nature of the endogenous gluco-
corticoid system, only a handful of studies have investigated how
these rapid ultradian glucocorticoid ﬂuctuations affect the tran-
scription and mRNA expression of glucocorticoid-regulated genes
(Conway-Campbell et al., 2007a, 2010, 2011; McMaster et al., 2011;
Stavreva et al., 2015; 2009; Sarabdjitsingh et al., 2010; Morsink
et al., 2006a, 2006b).
Glucocorticoids diffuse readily from the blood into target cells
and can bind intracellular glucocorticoid receptors (GR) and
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mineralocorticoid receptors (MR) which act as ligand-activated
transcription factors that can interact with promoter and
enhancer regions to mediate the activation or repression of
glucocorticoid-regulated genes. Previous studies have demon-
strated that GR responds dynamically to ultradian pulses of cortisol
and corticosterone. In cell lines and in tissue, corticosterone pulses
at 60 min intervals result in cyclical waves of GR:DNA binding and
nascent RNA production that increase as corticosterone levels rise
and rapidly decrease as corticosterone levels fall (Conway-
Campbell et al., 2007a, 2010, 2011; Stavreva et al., 2015). Howev-
er, the effects of pulsatile glucocorticoid exposure on the temporal
dynamics of mRNA levels have currently been limited to cell lines
(Stavreva et al., 2009; McMaster et al., 2011; Morsink et al., 2006a,
2006b), and the liver (Stavreva et al., 2009) and hippocampus
(Conway-Campbell et al., 2010) of rats.
GR nuclear translocation and activity is known to vary in
different brain regions and cell types (Kitchener et al., 2004; de
Kloet et al., 1975; McEwen et al., 1986; Spiga and Lightman,
2009). Therefore we have investigated two important
glucocorticoid-target tissues, the prefrontal cortex (PFC) of the
brain, and the pituitary, in which ultradian responses have not
been studied. The pituitary is the primary site of glucocorticoid-
dependent negative feedback and the PFC is a highly sensitive
glucocorticoid-target region required for working memory and
executive function (Roozendaal et al., 2004; Cerqueira et al., 2005;
Butts et al., 2011; Kesner and Churchwell, 2011; McEwen and
Morrison, 2013). Our in vivo studies into the effects of ultradian
glucocorticoid exposure have, to date, been limited to the ‘hy-
persensitive’ (Reddy et al., 2012) glucocorticoid-responsive
circadian clock gene Period 1 (Stavreva et al., 2009; Conway-
Campbell et al., 2010). We have now extended our assessment
to two well-known glucocorticoid responsive genes. Serum/
glucocorticoid regulated kinase 1 (Sgk1) and Tsc22d3 (Glucocorti-
coid-induced leucine zipper (Gilz)) in the PFC, and Pro-opiomela-
nocortin (Pomc) in the pituitary. Sgk1 is a widely expressed kinase
that is regulated by glucocorticoids via a regulatory DNA element
approximately 1 kb upstream of the transcriptional start site (TSS)
(Webster et al., 1993a; Maiyar et al., 1997; Sato et al., 2008). SGK1
has been proposed to play a role in a wide range of functions,
regulating both genomic and non-genomic actions and has been
implicated in the regulation of many neuronal processes such as
neuronal excitability, excitotoxicity, oligodendrocyte morphology,
hippocampal plasticity and memory function (Tsai et al., 2002;
Miyata et al., 2011; Lang et al., 2006, 2010). Gilz mRNA, tran-
scribed from the Tsc22d3 gene, is ubiquitously induced in the rat
brain following corticosterone injections (albeit with tissue-
speciﬁc variations in transcript level) and contains two gluco-
corticoid response element (GRE) sites within a 2500bp region
upstream of the TSS (Wang et al., 2004; van der Laan et al., 2008;
Yachi et al., 2007). Whilst its function in the brain remains unclear,
Gilz is known to modulate apoptosis, with anti-proliferative ef-
fects in immune cells and the thymus (Riccardi et al., 1999; Ayroldi
et al., 2007).
In this study we extend the current understanding of the ef-
fects of ultradian corticosterone exposure in living tissue, by
investigating the response of these glucocorticoid-regulated
genes. Using our established rat model of pulsatile corticoste-
rone administration (Stavreva et al., 2009; Conway-Campbell
et al., 2010) and a candidate gene approach, the following ques-
tions were explored: 1) Can ultradian corticosterone exposure
direct unique and gene-speciﬁc regulation within the same tis-
sue? 2) What are the dynamics of a glucocorticoid-repressible
gene during ultradian corticosterone exposure? 3) Will the same
gene exhibit similar or different expression proﬁle dynamics in
different tissues?
2. Materials and methods
2.1. Animals
Adult male Sprague Dawley rats (250e300 g; age 10e11 weeks)
were obtained from Harlan Laboratories (Bicester, UK) and main-
tained under standard housing conditions with a 14:10 light/dark
cycle (lights on 5.15 a.m./off 7.15 p.m.). Food and water (or saline
when speciﬁed) were available ad libitum. All procedures were
conducted in accordance with the UK Home Ofﬁce guidelines and
the UK Animals (Scientiﬁc Procedures) Act.
2.2. Surgery & pulsatile corticosterone treatment
Surgical procedures and pulsatile treatment of exogenous
corticosterone were carried out as previously described (Stavreva
et al., 2009; Conway-Campbell et al., 2010). Rats received a bilat-
eral adrenalectomy (ADX) and jugular cannulation under balanced
general anaesthesia (veterinary isoﬂurane; Merial Animal Health
Ltd., UK). Post-surgery, rats received subcutaneous injections (SC)
of 0.2 mg/ml Rimadyl (Carprofen 5% w/v, Benzyl alcohol 1% w/v;
Pﬁzer Ltd., UK) diluted in sterile 10 IU/ml heparinised saline and
2.5 ml SC glucose saline (Sodium chloride 0.45% w/v and Glucose
2.5% w/v solution for infusion BP; Baxter Healthcare Ltd., UK) to aid
recovery.
Animals recovered for 5 days post-surgery, during which time
they received corticosterone replacement in the drinking water
(0.9% saline supplemented with 15 mg/ml corticosterone (Sigma-
Aldrich, UK) solubilised in 0.01% v/v absolute ethanol). Corticoste-
rone was withdrawn 24 h prior to the experiment and replaced
with 0.9% saline for drinking. On day 6, rats received up to four
intravenous (IV) pulses of 100 mg corticosterone via the jugular
cannula in the form of a water-soluble complex of corticosterone
and 2-hydroxypropyl-b-cyclodextrin (corticosterone-HBC; C-174;
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Fig. 1. The corticosterone proﬁle of rats during ultradian treatment. Administration
of four IV bolus injections (‘hourly pulses’) of 100 mg exogenous corticosterone at
exactly 0, 60, 120 and 180 min (a) results in the distinctive circulating corticosterone
proﬁle in adrenalectomised rats (b). Pulsatile glucocorticoid levels in the bloodstream
(measured in plasma samples by RIA) rise rapidly within 1 min of each corticosterone
administration and return to baseline levels within 60 min, temporally modelling the
endogenous rhythm of ultradian glucocorticoid dynamics. All data expressed as
mean ± s.e.m. One-way ANOVA revealed a signiﬁcant effect of time (P < 0.0001). In-
dividual signiﬁcant differences, determined by Dunnett's post hoc test with 0 min used
as control, are indicated (****P < 0.0001).
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Sigma-Aldrich, USA) at times 0, 60, 120 and 180 min. Blood samples
were obtained by sampling directly from the cannula immediately
prior to each corticosterone injection and 1 min post-injection for
corticosterone radioimmunoassay (RIA). Animals were euthanized
via overdose of IV sodium pentobarbital at the deﬁned timepoints
indicated in the graphs in Figs. 2e5. Trunk bloods (TB) were
collected and stored at 20 C for RIA analysis and PFC and pitui-
taries were rapidly dissected, frozen in liquid nitrogen and stored
at 80 C.
2.3. Corticosterone radioimmunoassay (RIA)
Plasma samples were diluted 1 in 50 with citrate buffer (pH 3.0).
Total plasma corticosterone levels were measured from blood
samples with an in-house RIA as previously described (Atkinson
et al., 2006; Spiga et al., 2007; Waite et al., 2012) using a speciﬁc
Fig. 2. Ultradian corticosterone exposure results in differential gene-speciﬁc mRNA
expression proﬁles for Gilz and Sgk1 in the PFC. (a) Four consecutive hourly pulses of
100 mg of exogenous corticosterone resulted in a signiﬁcant induction of Gilz mRNA in
the PFC (P < 0.0001; One-way ANOVA) with a notably delayed induction observed.
Consistent with the visibly delayed induction proﬁle, Tukey's multiple comparison
tests determined that GilzmRNA levels did not reach statistical signiﬁcance (relative to
baseline, time 0) until 150 min. Gilz mRNA levels then remained signiﬁcantly elevated
throughout the time course including at 300 min. Asterisks above individual bars
indicate signiﬁcant differences compared to time 0 min (* ¼ P < 0.05, ** ¼ P < 0.01,
*** ¼ P < 0.001). In comparison, Sgk1mRNA (b) increased more rapidly, with a trend of
increase as early as 30 min, reaching signiﬁcantly elevated levels by 120 min then
decreasing by 270 min. One-way ANOVA indicated the effect was signiﬁcant
(P < 0.0001), and the results of Tukey's multiple comparison tests are shown on the
graph. Asterisks above individual bars indicate signiﬁcant differences for each time-
point compared to baseline time 0 min (* ¼ P < 0.05, ** ¼ P < 0.01, *** ¼ P < 0.001), and
$ symbols above individual bars indicate signiﬁcant difference compared to time
300min ($ ¼ P < 0.05, $$ ¼ P < 0.01, $$$ ¼ P < 0.001). All data were normalised to b-actin
and expressed as mean ± s.e.m.
Fig. 3. Ultradian glucocorticoid exposure results in downregulation of Pomc in the
pituitary. Four consecutive hourly pulses of 100 mg of exogenous corticosterone
resulted in a signiﬁcant (P < 0.0001; One-way ANOVA) reduction of Pomc hnRNA in the
pituitary with a notably delayed effect observed. A trend to increased Pomc hnRNA
levels was observed at 60 min, although this was not signiﬁcant (Tukey's multiple
comparison post-test; P > 0.05). A ‘pulsatile’ repression of Pomc hnRNA was evident
from the second pulse application. Results from Tukey's multiple comparison tests are
indicated on the graph, where statistical signiﬁcance was found. Asterisks on the in-
dividual timepoints of 90, 150 and 210 min indicate individual comparisons to control
time 0 (* ¼ P < 0.05, ** ¼ P < 0.01, *** ¼ P < 0.001), consistent with a pulsatile
repression of Pomc 30 min after the consecutive corticosterone pulses administered at
60, 120 and 180 min. There was a lack of signiﬁcant difference from control time 0 for
times 120, 180 and 240 min, consistent with a transient repression after each pulse.
Signiﬁcant reduction in Pomc hnRNA levels at 90 min and then throughout the
timecourse were evident only in the Tukey's comparisons to the 60 min timepoint,
with individual results indicated by the $ symbol ($ ¼ P < 0.05, $$ ¼ P < 0.01,
$$$ ¼ P < 0.001, $$$$ ¼ P < 0.0001). All data were normalised to b-actin and expressed as
mean ± s.e.m.
Fig. 4. Pulsatile Sgk1 mRNA in the pituitary during pulsatile corticosterone
exposure. Four consecutive hourly pulses of 100 mg of exogenous corticosterone
resulted in a signiﬁcant (P < 0.0001; One-way ANOVA) induction of Sgk1 mRNA in the
pituitary. A signiﬁcant upregulation of Sgk1 mRNA occurred at 60 min in response to
the ﬁrst pulse. Consecutive pulses appear to then establish further transient increases
in Sgk1 mRNA at times 90, 150 and 210 min i.e. 30 min after each pulse. Tukey's
multiple comparison tests revealed that the highest signiﬁcant differences, relative to
baseline time 0, were found at times 90, 150 and 210 min represented by ****
(P < 0.0001), while lesser inductions were evident at times 60, 120, 180, 240 and
270 min (** ¼ P < 0.01). The highest signiﬁcant differences relative to time 300 min (i.e.
120 min after cessation of pulsing) were found at times 90, 150 and 210 min, repre-
sented by $ symbols ($$ ¼ P < 0.01, $$$$ ¼ P < 0.0001). All data were normalised to b-
actin and expressed as mean ± s.e.m.
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rabbit anti-rat corticosterone primary antibody (kindly supplied by
G. Makara, Institute of Experimental Medicine, Budapest, Hungary).
The intra- and inter-assay coefﬁcients of variation of the cortico-
sterone assay have previously been established as 16.7% and 13.3%,
respectively (Spiga et al., 2011).
2.4. Nuclear extract preparation
The nuclear extraction procedure was performed as previously
described (Conway-Campbell et al., 2007a, 2010; Stavreva et al.,
2009; Kitchener et al., 2004; Vallone et al., 1997). Brieﬂy, frozen
PFC samples (both hemispheres) or whole pituitaries were homo-
genised using a Dounce homogeniser in 1 ml (PFC) or 300 ml (pi-
tuitaries) of S1 buffer (10 mM HEPES (pH7.9), 10 mM KCL, 1.5 mM
MgCl2, 0.1 mM EDTA (pH8.0), supplemented with 2 mM NaF,
0.2 mM sodium orthovanadate, 0.5 mM DTT, and Complete™ Pro-
tease Inhibitor Cocktail (Roche Diagnostics Ltd., UK)) to release
nuclei. The nuclear pellets were resuspended in 1.2 vol of cold S2
buffer (10 mM HEPES (pH 7.9), 400 mM NaCl, 1.5 mM MgCl2,
0.1 Mm EDTA (pH 8), and 5% glycerol, supplemented with 2 mM
NaF, 0.2 mM Na orthovanadate, 0.5 mM DTT, and Complete™
Protease Inhibitor Cocktail) and stored in aliquots at80 C. Protein
concentrations were assessed using a bicinchoninic acid (BCA)
protein assay (Pierce, Rockford, IL).
2.5. Western blotting
Western blotting procedures followed the original method-
ology of SDS PAGE electrophoresis described by Laemmli
(Laemmli, 1970) and performed as previously described
(Conway-Campbell et al., 2007a, 2007b, 2008). For each sample
10 mg of nuclear extract was run on 7.5e15% polyacrylamide gels
and transferred to polyvinylidene ﬂuoride (PVDF) membrane (GE
Healthcare UK Ltd., UK). Membranes were blocked overnight at
4 C in 5% non-fat skimmed milk powder in Tris-buffered saline/
Tween (TBST; 30 mM Tris-HCL pH7.6, 140 mM NaCl, 0.1% Tween-
20) before probing with GR M-20 antibody (sc-1004, Santa Cruz)
at 1:1000 (upper membrane) in 0.5% non-fat skimmed milk
powder in TBST or anti-Lamin A/C (2032, Cell Signalling Tech-
nology, Boston MA) at 1:1000 (lower membrane) in TBST, both
for 1 h at room temperature on a rotating platform then incu-
bated with Horse-Radish Peroxidase (HRP) conjugated secondary
antibodies (anti-rabbit IgG-HRP NA934V, GE Healthcare UK Ltd.
for GR) at 1:10,000 in 5% non-fat skimmed milk powder in TBST
for 1 h. Membranes were treated with enhanced chem-
iluminescence (ECL) reagent (ECLPlus, Biological Industries,
Israel) and signal detected using enhanced chemiluminescence
hyperﬁlm (GE Healthcare UK Ltd). Results were quantiﬁed by
densitometry using an Epson perfection scanner (Epson Europe,
Netherlands) in professional mode 16-bit grey-scale. Data were
analysed using Image J Densitometry Software (http://imagej.nih.
gov/ij) with adjusted volume OD for GR, normalised to total
protein loaded and expressed as fold-change relative to the time
0 control for each tissue type.
2.6. RNA extraction
Total RNA from both prefrontal cortices and whole pituitaries
was extracted using TRizol reagent (Invitrogen, Life technologies
Ltd., UK) and using Heavy Phase-Lock-Gel tubes (5 PRIME, USA) to
increase RNA recovery. The recovered supernatant was subjected to
a second puriﬁcation step via incubation with an equal volume of
24:1 chloroform:isoamyl alcohol (Sigma-Aldrich, UK). Samples
were then processed using Qiagen RNeasy Mini Kit (Qiagen, UK)
with an on-column DNAse digestion (Qiagen RNase-Free DNase kit,
UK), after which RNA aliquots were stored at 80 C.
2.7. RT-qPCR
RNA concentrations were quantiﬁed by a NanoDrop ND-1000
Spectrophotometer (NanoDrop Technologies, USA). All samples
Fig. 5. Pituitary and prefrontal cortex exhibit differences in Sgk1 mRNA
expression proﬁles and GR activation dynamics during pulsatile corticosterone
treatment. Differences in Sgk1 mRNA expression proﬁles between the pituitary and
PFC can be visualised in the overlaid data plot (a). A signiﬁcant differential effect of
tissue type is statistically supported by two-way ANOVA, with signiﬁcant effects of
both time (P < 0.0001) and tissue (P < 0.0001), with a signiﬁcant interaction
(P < 0.0001). Signiﬁcant differences comparing between the pituitary and PFC at
each time point are indicated in with $ symbols ($ ¼ P < 0.05, $$ ¼ P < 0.01; Sidak's
post-tests). (b) Active GR is measured by the level of GR detected in the high-salt
extracted nuclear fraction by western blot. Representative western blot showing a
single band which resolves at approximately 97 kDa detected by the anti-GR anti-
body M20 (sc-1003) (upper box) in pituitary and prefrontal cortex nuclear extracts
prepared from rats at times indicated after a single corticosterone pulse. Lamin A/C
(nuclear extract control protein detected with antibody 2032, Cell Signalling Tech-
nology) is shown in the lower box, resolving as a double band at approximately
65 kDa and 70 kDa in the pituitary and a single band at approximately 65 kDa in the
PFC. (c) Summary graph of western blot semi-quantitative densitometry data
showing fold-change in GR detected in the nuclear fraction relative to time 0 for
each tissue type. Two-way ANOVA indicated a signiﬁcant effect of time after
treatment (P < 0.0001), tissue response (P < 0.0001) and interaction (P < 0.0001).
Multiple comparison test results are shown on graph. Signiﬁcant differences
compared to time 0 are indicated by asterisks (** ¼ P < 0.01, *** ¼ P < 0.001,
**** ¼ P < 0.0001; Tukey's post-tests), and signiﬁcant differences between pituitary
and PFC at each time point, are indicated by $ symbols ($ ¼ P < 0.05, $$ ¼ P < 0.01;
Sidak's post-tests).
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possessed a 260:280 ratio of 1.8e2.2 and 260:230 ratio above 1.9.
cDNA conversions were performed using 1 mg of RNAwith the AMV
ﬁrst-strand synthesis kit (Invitrogen, Life Technologies Ltd., UK) on
a G-Storm GS1 thermal cycler (Gene Technologies Ltd., UK). Control
samples omitting the AMV RT enzyme were run in parallel. RT-
qPCR reactions were performed on the ABI Prism 7500 Sequence
Detection System (Applied Biosystems, UK). Pomc hnRNA expres-
sion was quantiﬁed using 50 ng of cDNA input with a custom
designed FAM-dye-labelled Taqman expression assay (Forward:
50eACTAGAGGGCAGGGATGGT-30, Reverse: 50eGGGAGGCCCAATG
TGTGA-30, FAM probe: 50eCCAAGCCAGCTCCTG-30) normalised to
b-actin mRNA (ABI assay no. 4352931E; Applied Biosystems, UK),
performed with TaqMan Universal PCR Master Mix (Applied Bio-
systems). Sgk1 and Gilz (Tsc22d3) mRNA expression levels were
quantiﬁed relative to b-actin mRNA expression using 100 ng of
cDNA per replicate. Ampliﬁcation reactions were performed with
Power SYBR Green Master Mix (Applied Biosystems) and custom
SYBR green primers at a working concentration of 2 mM (Sigma-
Aldrich, UK; Sgk1 mRNA: Forward: 50-CGTACGACCGGACAGTGGA-
30, Reverse 50-GATATTTGGTTTCAGCTGGAGAGG-3’; Gilz mRNA:
Forward: 50eCCATGGATCTAGTGAAGAATCATTTG-30, Reverse:
30eCCACCTCCTCTCTCACAGCATAC-50, b-actin mRNA: Forward: 50-
CTTCTTGCAGCTCCTCCGTC-30, Reverse: 50-ATATCGTCATCCATGGC-
GAAC-30). Standard curves conﬁrmed that the ampliﬁcation efﬁ-
ciency of all primers fell within the recommended ABI guidelines of
100 ± 10% efﬁciency and thus transcripts were quantiﬁed using the
comparative DDCt method. Dissociation curves were performed for
all SYBR Green assays and used for quality control. Ct values were
deﬁned using automatic thresholds and baseline settings using
Sequence Detection Software (version 1.2.3; Life Technologies Ltd.,
UK).
2.8. Statistics
Microsoft Excel 2008 for Mac (version 12.3.6) was used for raw
data analysis. Graphs and statistics were performed using Graph-
Pad Prism Version 6 for Mac OS X. All graphs and data in text are
expressed as mean (M) ± s.e.m, with a minimum n number per
group of 3. One-way ANOVAs were used to analyse the timecourse
data, and Tukey's or Dunnett's multiple comparison post-hoc tests
were then used where appropriate. Gene-speciﬁc and tissue-
speciﬁc effects in the data were assessed using two-way ANOVA,
followed by Tukey's or Sidak's multiple comparison post-hoc tests
where appropriate.
3. Results
3.1. Pulsatile corticosterone treatment model
Rapid rises in plasma corticosterone levels were observed
1 min after the hourly administration of each corticosterone
‘pulse’ (Fig. 1), providing a circulating corticosterone proﬁle
consistent with our previously described model of ultradian
glucocorticoid replacement (Stavreva et al., 2009; Conway-
Campbell et al., 2010). Plasma corticosterone cleared to basal
levels within 60 min of each pulse, consistent with the 8e9 min
half life of corticosterone clearance in vivo. This proﬁle temporally
models the hourly intervals observed with endogenous ultradian
glucocorticoid secretion (Windle et al., 1998a, 1998b; Stavreva
et al., 2009; Conway-Campbell et al., 2010), and will be the
model used throughout the present study for downstream
assessment of transcriptional rhythmic responsiveness in the PFC
and pituitary.
3.2. Ultradian glucocorticoid exposure directs gene-speciﬁc mRNA
expression in the PFC
Striking differences in mRNA expression proﬁles for Gilz and
Sgk1 were apparent over the 5 h timecourse of ultradian cortico-
sterone treatment. Gilz mRNA (Fig. 2a) levels remained at a low
plateau during the ﬁrst three corticosterone pulses, only increasing
signiﬁcantly above basal levels at 150 min (M ¼ 1.65 ± 0.08 fold
induction, P < 0.01), suggesting at least three consecutive cortico-
sterone pulses were required to induce an increase in expression of
this transcript. Gilz mRNA then remained signiﬁcantly elevated
throughout the timecourse up to 300 min, which is 120 min after
the ﬁnal pulse. In contrast, Sgk1 mRNA (Fig. 2b) expression
increased more rapidly after the ﬁrst corticosterone pulse and was
signiﬁcantly elevated relative to baseline levels (0 min) by 120 min
(M ¼ 1.81 ± 0.15 fold induction, P < 0.01), then continued to in-
crease until 210 min (M ¼ 2.10 ± 0.18 fold induction, P < 0.001). At
240 min (60 min after the ﬁnal corticosterone pulse) Sgk1 mRNA
levels began to rapidly fall, returning to baseline levels by 300 min
(M ¼ 0.83 ± 0.03 fold induction, P > 0.05).
3.3. Pulsatile repression of Pomc hnRNA in the pituitary
Previous studies into ultradian glucocorticoid exposure in vivo
have primarily focused on upregulated genes. Glucocorticoids
however, can also act as negative regulators of gene expression,
inhibiting the transcription of numerous important target genes to
exert many of their physiological effects (De Bosscher et al., 2003).
The negative feedback arm of the HPA axis for instance, involves
glucocorticoids acting on pituitary corticotrophs to directly inhibit
transcription of the Pomc gene which encodes precursors to the
hormone adrenocorticotrophic hormone (ACTH) that stimulates
corticosterone secretion (Birnberg et al., 1983). Pomc mRNA has,
however, a particularly long half life (up to 24 h (Birnberg et al.,
1983)) which may mask the direct transcriptional changes
induced by glucocorticoids over this short time period. The nascent
transcript (hnRNA) of the Pomc gene in the rat pituitary was
therefore investigated to assess the direct transcriptional effects of
pulsatile glucocorticoid exposure (Fig. 3). In contrast to the rapid
Sgk1mRNA induction seen in the PFC (Fig. 2b) and Per1 hnRNA seen
in the liver and hippocampus (Stavreva et al., 2009; Conway-
Campbell et al., 2010), no signiﬁcant changes in Pomc hnRNA
expression were detected in response to the ﬁrst corticosterone
pulse. In addition to a lack of downregulation of Pomc hnRNA in
response to the ﬁrst pulse, there was a trend (not signiﬁcant) of an
increase at 60 min. Each subsequent pulse then appeared to tran-
siently reduce Pomc hnRNA, with notable decreases evident at
90 min (suppression; M ¼ 0.56 ± 0.19), 150 min (suppression;
M¼ 0.55 ± 0.13) and 210min (suppression;M¼ 0.44 ± 0.05). Minor
recovery of suppression was evident at 120 min (suppression;
M ¼ 0.68 ± 0.22), 180 min (suppression; M ¼ 0.75 ± 0.25), and
240 min (suppression; M ¼ 0.55 ± 0.19). One-way ANOVA
conﬁrmed that the variation over time was statistically signiﬁcant
(P < 0.0001), therefore Tukey's multiple comparison tests were
then used to assess the signiﬁcance of the observed ‘pulsatile’
repression of Pomc hnRNA. Signiﬁcance at the individual time-
points 90,150 and 210min (Fig. 3) indicated comparisons to control
time 0, and therefore supported a pulsatile repression at 30 min
after consecutive corticosterone pulses. There was no signiﬁcant
difference for times 120, 180 and 240 min compared to time 0,
presumably due to the minor recovery from repression at these
times, which are exactly 60 min after each consecutive pulse. A
signiﬁcant reduction in Pomc hnRNA levels at 90 min and then
throughout the timecourse (Fig. 3) were evident only in the Tukey's
post-test comparisons to the 60 min timepoint. Taken together
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these data are consistent with a pulsatile regulation of the Pomc
transcript at a new lower set-point, established by at least two
consecutive pulses.
3.4. Pulsatile induction of SGK1 mRNA in the pituitary
In order to explore potential tissue-speciﬁc responses to
ultradian glucocorticoid exposure, we compared the mRNA
expression proﬁle of Sgk1 in the pituitary to its expression proﬁle
in the PFC. Similar to its early induction in the PFC, pituitary Sgk1
mRNA (Fig. 4) increased rapidly after the ﬁrst corticosterone pulse,
reaching M ¼ 1.83 ± 0.05-fold induction by 60 min. Pituitary Sgk1
mRNA then continued to increase further after each consecutive
corticosterone pulse reaching a maximal M ¼ 2.84 ± 0.45-fold
induction at 210 min. Levels then decreased within 30 min of
the ﬁnal pulse application, decreasing to M ¼ 2.04 ± 0.16-fold at
270 min, and returning to near baseline levels of M ¼ 1.41 ± 0.03-
fold at 300 min.
Unlike the steady increase of Sgk1mRNA seen in PFC throughout
the pulsatile corticosterone timecourse, pituitary Sgk1 mRNA
exhibited a distinctive pulsatile pattern that corresponded to each
corticosterone pulse. Interestingly, the pulsatile pattern was only
seen after the initial induction at 60 min i.e. further signiﬁcant
increases in Sgk1 expression were evident at 30 min after the sec-
ond, third and fourth corticosterone pulses at 60, 120 and 180 min
respectively. These subsequent, relatively transient, inductions rose
in response to each pulse then decreased with the falling phase of
the pulse. As described for the analysis of the pulsatile repression in
pituitary, Tukey's multiple comparison tests statistically conﬁrmed
extremely signiﬁcant induction of Sgk1 mRNA in pituitary relative
to baseline time 0, at times 90, 150 and 210 min (P < 0.0001). Sig-
niﬁcant inductions, albeit to a slightly lesser extent, were also
detected at times 60, 120, 180, 240 and 270 min (P < 0.01). Signif-
icant differences, relative to levels at time 300 min (i.e. 120 min
after ﬁnal injection), were again found at the times corresponding
to each pulse peak i.e. 90,150 and 210min, as shown in Fig. 4. Taken
together these data are consistent with pulsatile regulation of pi-
tuitary Sgk1 mRNA at a raised set-point established after the ﬁrst
pulse.
3.5. Tissue-speciﬁc Sgk1 mRNA expression patterns are revealed
during ultradian glucocorticoid exposure
Fig. 5a contrasts the pulsatile Sgk1 mRNA expression proﬁle in
the pituitary with the more continuous rise in Sgk1 mRNA
expression in the PFC. The differing tissue-speciﬁc temporal
expression proﬁles of Sgk1 mRNA between the PFC and the pitui-
tary were conﬁrmed by two-way ANOVA with highly signiﬁcant
effects of time (F (10,83) ¼ 17.46, P < 0.0001), tissue (F
(1,83) ¼ 42.82, P < 0.0001), and interaction (F (10,83) ¼ 3.10,
P < 0.01). Tukey's multiple comparison test results for signiﬁcant
effects over time in each tissue type are shown in Figs. 3 and 4, and
results from comparisons between tissue types (Sidak's multiple
comparison tests) are shown in Fig. 5a. Basal expression of Sgk1 is
not signiﬁcantly different between the two tissues types, either at
baseline (time 0) or at the time of each pulse nadir (times 60, 120
and 180 min). However, signiﬁcantly higher levels of Sgk1 mRNA
are evident in the pituitary at 30 min after the second, third and
forth pulse, suggesting a more dynamic range for Sgk1 mRNA
regulation in the pituitary compared to the PFC. As this might be
the effect of a more dynamic range of GR response to pulsatile
glucocorticoid exposure in the pituitary than the PFC, we tested for
tissue-speciﬁc differences in GR activation in the two tissue types.
3.6. Tissue-speciﬁc decoding of ultradian glucocorticoid exposure
To assess GR activation proﬁles over time after a pulse of
corticosterone in the two tissues, we measured GR levels in the
chromatin-rich nuclear fraction prepared from the ex vivo tissue
samples, a reliable assay of GR activity (Conway-Campbell et al.,
2007a, 2010; Kitchener et al., 2004; Yang et al., 1978). Western
blots of the resulting nuclear extracts provided relative quantita-
tion data for GR levels in the nuclear fraction over the timecourse
after a single glucocorticoid pulse. A representative western blot
(Fig. 5b) shows low nuclear GR levels at time 0 in both the pituitary
and PFC. A rapid increase was evident by 5 min in both tissue types,
with a much larger response in the pituitary than in the PFC. Pi-
tuitary nuclear GR levels then remained high at 10 min, decreased
at 15 min and returned to baseline levels by 30 min. In contrast,
nuclear GR in the PFC samples remained at elevated levels for the
full 30 min before returning to baseline by 60 min. Semi-
quantitative densitometry data from the full dataset was
expressed as mean fold-change relative to baseline for ﬁve time-
points taken over the ﬁrst hour after a single corticosterone pulse,
for both pituitary and PFC (Fig. 5c). Two-way ANOVA indicated a
signiﬁcant effect of time (P < 0.0001) and tissue response
(P < 0.0001), with a signiﬁcant interaction (P < 0.0001). Tukey's
multiple comparison post-tests conﬁrmed signiﬁcant differences
compared to time 0 at times 5,10 and 15min for pituitary, and 5,10,
15 and 30 min for PFC. The results of Sidak's multiple comparison
tests, comparing the pituitary vs PFC GR response at each matched
timepoint is indicated by the $ symbols in the graph in Fig. 5c. Here,
signiﬁcant differences are seen at times 5, 10 and 15 min due to the
signiﬁcantly higher GR response in pituitary than PFC. Conversely
at 30 min a signiﬁcant difference is seen due to the signiﬁcantly
higher GR response in the PFC than pituitary. Importantly, no sig-
niﬁcant differences were detected at times 0 or 60 min. Taken
together, these data indicate that the PFC exhibits quite different GR
activation dynamics compared to the pituitary, with a lower initial
maximal amplitude which persists for longer after the corticoste-
rone pulse.
4. Discussion
4.1. Gene-speciﬁc differences in dynamic regulation of Gilz and
Sgk1 mRNA in the PFC
The differences in mRNA expression proﬁles of the two
glucocorticoid-target genes Gilz and Sgk1 in the PFC during ultra-
dian glucocorticoid treatment are a result of: 1) a delayed induction
of GilzmRNA compared to Sgk1 and 2) a more rapid decline of Sgk1
mRNA following the cessation of pulses. Several factors that inﬂu-
ence the rate of transcription, and stability/degradation of mRNA
might explain these differences. Certainly, these intrinsic properties
of transcriptional regulation and mRNA stability will enable com-
plex digital decoding of the pulsatile glucocorticoid signal in a
transcript-dependent manner.
4.2. Pulsatile gene regulation in pituitary
Elevated Pomc hnRNA levels in the early timepoints are most
likely due to ADX-induced CRH and vasopressin release at the hy-
pothalamic level, with expression levels renormalizing with corti-
costerone replacement. Once the new set-point is established, the
rhythmic repression of Pomc directed by each pulse of corticoste-
rone becomes evident. The delayed repression of Pomc hnRNA is
also consistent with genome-wide studies in A549 cells showing
that the majority of transcriptional downregulation occurs slightly
later than that of transcriptional induction (Reddy et al., 2009) and
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with reports of a combinatorial regulatory mechanism for tran-
scriptional repression of glucocorticoid-target genes (Cho and Kim,
2009). Consistent with this, induction of pituitary Sgk1 occurred
rapidly with increased mRNA levels detected after the ﬁrst pulse.
Distinctive pulsatile increases in Sgk1mRNA continued throughout
the timecourse of pulsatile glucocorticoid exposure, establishing a
higher oscillating set-point of Sgk1 expression, which only
decreased to baseline levels after the last pulse. To date the ‘gene
pulsing’ phenomenon has only been described for nascent tran-
script production i.e. hnRNA. Therefore Sgk1 is the ﬁrst transcript
found to exhibit pulsatile regulation at the mature mRNA level in
our studies, presumably due to its reported short half life of 20 min
(Webster et al., 1993b).
4.3. Tissue-speciﬁc differences between pituitary and PFC
The ability of different tissues to interpret pulses of corticoste-
rone into either pulsatile or continuous mRNA expression levels of
the same gene represents a new level of plasticity in the gluco-
corticoid response. Broadly speaking there are two main possibil-
ities that could explain tissue-speciﬁc Sgk1 mRNA expression
pattern differences: 1) The transcriptional responsiveness of the
tissue to ultradian corticosterone exposure, namely via the
magnitude or the dynamics of tissue-speciﬁc GR responsiveness;
Or 2) An effect of factors downstream of GR activation, which also
regulate gene-speciﬁc temporal proﬁles. Examples of these
downstream factors may include gene-speciﬁc chromatin modiﬁ-
cations, or factors affecting the rate of transcription, or mRNA sta-
bility and degradation.
Tissue-speciﬁc corticosterone exposure levels determined by
blood-brain barrier penetration and 11-b-HSD activity may affect
the overall magnitude or duration of GR binding, as may tissue-
speciﬁc differences in GR expression level or factors such as dif-
ferential HSP90 activity inﬂuencing translocation. Although the
kinetics of rising and falling corticosterone levels have been found
to be the same in the periphery and the brain by microdialysis, free
cortisol concentrations have been found to be slightly higher in the
periphery (Qian et al., 2012). Furthermore, despite several studies
reporting similar levels of free-corticosterone in different brain
regions (Kitchener et al., 2004; Droste et al., 2008, 2009), region-
speciﬁc GR binding and translocation proﬁles have been observed
both within the brain (e.g. the hippocampus and PFC), and when
compared to the pituitary (Kitchener et al., 2004; de Kloet et al.,
1975; Spiga and Lightman, 2009; Spencer et al., 1990; 1991;
McEwen, 1976). Here we report that GR activation exhibited a
greater ‘dynamic range’ in pituitary, compared to PFC, over the
60 min duration after a single corticosterone pulse. The capacity for
a larger GR response in pituitary compared to PFC is already well
established (Spiga and Lightman, 2009), however the marked dif-
ference in temporal dynamics between the two tissues was quite
intriguing. Despite the initial higher amplitude, the pituitary GR
response to a pulse of corticosterone was markedly more transient
than that observed in the PFC.
Additional factors that could contribute to tissue-speciﬁc dif-
ferences in Sgk1mRNA expression include the confounding impact
of cellular heterogeneity in different tissue types, which may
dampen a synchronised transcriptional response in the PFC. In
particular the medial and orbital divisions of the rodent PFC
respond with opposing actions to glucocorticoids and stress
(McEwen et al., 2016). Therefore, it will be very interesting to be
able to dissect out these two regions and assess their ultradian
glucocorticoid responsiveness separately when methodological
advances allow this in the future.
As disruption of ultradian glucocorticoid signalling resulting in
prolonged GR activation has been linked to pathological
consequences and implicated in manifestations of disease
(Lightman and Conway-Campbell, 2010), the results presented here
suggest that not all tissues or genes will be affected by ultradian
glucocorticoid disruption in the samemanner. Tissues or genes that
are highly sensitive to ultradian glucocorticoid exposure (e.g. those
producing pulsatile RNA expression) may be particularly prone to
transcriptional disturbance during the disruption of ultradian
glucocorticoid exposure by stress, disease or therapeutic gluco-
corticoid administration.
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